Discovery of a new series of [1,2,4]triazolo[4,3-a]quinoxalines as dual phosphodiesterase 2/phosphodiesterase 10 (PDE2/PDE10) inhibitors

被引:22
作者
Andres, Jose-Ignacio [1 ]
Buijnsters, Peter [2 ]
De Angelis, Meri [1 ]
Langlois, Xavier [3 ]
Rombouts, Frederik [2 ]
Trabanco, Andres A. [1 ]
Vanhoof, Greet [4 ]
机构
[1] Janssen Cilag SA, Janssen Res & Dev, Toledo 45007, Spain
[2] Janssen Pharmaceut NV, Janssen Res & Dev, Neurosci Med Chem, B-2340 Beerse, Belgium
[3] Janssen Pharmaceut NV, Janssen Res & Dev, Neurosci Biol, B-2340 Beerse, Belgium
[4] Janssen Pharmaceut NV, Janssen Res & Dev, CREATe, Translat Sci, B-2340 Beerse, Belgium
关键词
Neurological disorders; PDE2; inhibitors; PDE10; Triazoloquinoxalines; CGMP; PDE10A; CAMP; RAT; STRIATUM; MEMORY; BRAIN;
D O I
10.1016/j.bmcl.2012.11.077
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis, preliminary evaluation and structure-activity relationship (SAR) of a series of 1-aryl-4-methyl[1,2,4]triazolo[4,3-a]quinoxalines as dual phosphodiesterase 2/phosphodiesterase 10 (PDE2/PDE10) inhibitors are described. From this investigation compound 31 was identified, showing good combined potency, acceptable brain uptake and high selectivity for both PDE2 and PDE10 enzymes. Compound 31 was subjected to a microdosing experiment in rats, showing preferential distribution in brain areas where both PDE2 and PDE10 are highly expressed. These promising results may drive the further development of highly potent combined PDE2/PDE10 inhibitors, or even of selective inhibitors of PDE2 and/or PDE10. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:785 / 790
页数:6
相关论文
共 22 条
  • [1] Improving memory: A role for phosphodiesterases
    Blokland, A.
    Schreiber, R.
    Prickaerts, J.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (20) : 2511 - 2523
  • [2] Phosphodiesterases and cyclic nucleotide signaling in endocrine cells
    Conti, M
    [J]. MOLECULAR ENDOCRINOLOGY, 2000, 14 (09) : 1317 - 1327
  • [3] Biochemistry and physiology of cyclic nucleotide Phosphocliesterases: Essential components in cyclic nucleotide signaling
    Conti, Marco
    Beavo, Joseph
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2007, 76 : 481 - 511
  • [4] Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A)
    Fujishige, K
    Kotera, J
    Michibata, H
    Yuasa, K
    Takebayashi, S
    Okumura, K
    Omori, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18438 - 18445
  • [5] Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease
    Giampa, Carmela
    Laurenti, Daunia
    Anizilotti, Serenella
    Bernardi, Giorgio
    Menniti, Frank S.
    Fusco, Francesca Romana
    [J]. PLOS ONE, 2010, 5 (10):
  • [6] PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: A key step in parkinsonism physiopathology
    Giorgi, M.
    Melchiorri, G.
    Nuccetelli, V.
    D'Angelo, V.
    Martorana, A.
    Sorge, R.
    Castelli, V.
    Bernardi, G.
    Sancesario, G.
    [J]. NEUROBIOLOGY OF DISEASE, 2011, 43 (01) : 293 - 303
  • [7] Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
    Grauer, Steven M.
    Pulito, Virginia L.
    Navarra, Rachel L.
    Kelly, Michele P.
    Kelley, Cody
    Graf, Radka
    Langen, Barbara
    Logue, Sheree
    Brennan, Julie
    Jiang, Lixin
    Charych, Erik
    Egerland, Ute
    Liu, Feng
    Marquis, Karen L.
    Malamas, Michael
    Hage, Thorsten
    Comery, Thomas A.
    Brandon, Nicholas J.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02) : 574 - 590
  • [8] Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues
    Lakics, Viktor
    Karran, Eric H.
    Boess, Frank G.
    [J]. NEUROPHARMACOLOGY, 2010, 59 (06) : 367 - 374
  • [9] Lankau H. -J., 2012, Patent Application, Patent No. [WO 2012104293 A1 20120809, 2012104293]
  • [10] Isolation and characterization of PDE10A, a novel human 3′, 5′-cyclic nucleotide phosphodiesterase
    Loughney, K
    Snyder, PB
    Uher, L
    Rosman, GJ
    Ferguson, K
    Florio, VA
    [J]. GENE, 1999, 234 (01) : 109 - 117